Estrogen Replacement and Atherosclerosis (ERA) in Older Women

• Status: Completed
• Trial end date: 2000-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

To determine if estrogen replacement therapy, with or without low dose progesterone, slows progression or induces regression of coronary atherosclerosis in postmenopausal women.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Estrogens; Hormones; Progestins

Criteria

Postmenopausal women with established coronary atherosclerosis.